AI-generated summary
This review examines the inflammatory pathways shared by obesity and COVID-19, including oxidative stress, cytokine responses, and the ACE2 and RAAS systems, and reports that higher body mass index is related to greater COVID-19 risk across data from several countries. The authors also discuss photobiomodulation as one of several emerging obesity treatments under study. The abstract describes these as conceptual and narrative in nature, without a pooled analysis.
- Who or what was studied
- Obese individuals and people with COVID-19, including children under 13 years of age admitted to intensive care
- Limits stated in the abstract
- The abstract describes a narrative review with a conceptual outline and does not report a systematic search, pooled data, or quantitative results on photobiomodulation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oxidative stress, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.